1 – 10 of 208
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia
- Contribution to journal › Article
-
Mark
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta
- Contribution to journal › Article
-
Mark
Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model mice
- Contribution to journal › Article
-
Mark
Plasma p-tau immunoassays in clinical research for Alzheimer's disease
- Contribution to journal › Scientific review
-
Mark
Cell-weighted polygenic risk scores are associated with β-amyloid and tau biomarkers in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Characterizing the onset and progression of Alzheimer’s pathologies using amyloid and tau PET imaging and plasma p-tau217
- Contribution to journal › Article
-
Mark
Complementary utility of plasma biomarkers and Aβ-PET for diagnosis, risk-stratification, and treatment monitoring in Alzheimer's disease
- Contribution to journal › Debate/Note/Editorial
-
Mark
CSF markers of neuroinflammation, synaptic dysfunction and [18F]DOPA-PET in Parkinson's disease
- Contribution to journal › Article
-
Mark
A new blood biomarker for Alzheimer's disease
- Contribution to journal › Debate/Note/Editorial
-
Mark
Diagnostic and Prognostic Value of Blood and Cerebrospinal Fluid Biomarkers in Amyotrophic Lateral Sclerosis : A Systematic Review and Meta-Analysis
- Contribution to journal › Scientific review
